Immune-Priming & Prevention Strategies
Strengthening recurrence prevention through immunotherapy
Long-term recurrence prevention is a critical component of modern recurrent UTI management. In selected patients, immune modulation can play an important role in reducing infection frequency and supporting durable outcomes.
This standard defines how accredited centres assess, prescribe and monitor immune-based therapies within structured clinical pathways. The objective is responsible integration of immunostimulant strategies alongside diagnostic precision and targeted treatment.
The UTI Institute Accreditation recognises clinics that incorporate prevention-focused care models grounded in emerging scientific understanding.
Why this matters
Recurrent UTIs often result in repeated antibiotic exposure without addressing host susceptibility or immune response. In certain patient groups, recurrence patterns suggest the need for broader preventative strategies.
Immunostimulant therapies represent a shift from reactive treatment towards structured recurrence reduction. Applied appropriately, they can contribute to long-term stability and reduced antimicrobial dependence.
Accreditation formalises the careful, evidence-led use of immune-based interventions within accountable governance frameworks.
Structured capability across three interconnected domains
Clinics must operate within clearly defined eligibility criteria for immunostimulant therapy. Patient selection should be based on documented recurrence patterns, diagnostic findings and overall clinical context.
Accredited centres must demonstrate documented prescribing protocols and monitoring pathways. Treatment duration, follow-up intervals and response assessment criteria should be clearly defined.
Immunotherapy must be integrated within a broader management framework rather than used in isolation. Clear documentation should link immune-based treatment to overall recurrence reduction strategy.
Indicators of advanced practice
Who this standard is designed for
This accreditation pillar is intended for specialist clinics managing patients with recurrent UTIs where prevention strategies form part of long-term care planning.
It is suited to centres integrating immunostimulant therapies within structured, multi-modal treatment frameworks.
It is not designed for routine acute infection management alone.
Advancing the Global Standard
The UTI Institute Accreditation ensures advanced practice is applied systematically, responsibly and within defined governance frameworks. If your clinic reflects these principles, we invite you to formalise that expertise.